Chemicals Press Releases
SEE OTHER BRANDS

Following the chemical industry news from the world

Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

Press releases published on August 25, 2025

24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets

24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets

DENVER, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, revisits LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage …

Vornado Realty Trust to Purchase 623 Fifth Avenue

Vornado Realty Trust to Purchase 623 Fifth Avenue

Vornado Realty Trust 623 Fifth Avenue NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Vornado Realty Trust (NYSE:VNO) announced today that it has entered into an agreement to purchase the 623 Fifth Avenue office condominium, a 36-story, 382,500 rentable square …

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals

CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for …

HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market

HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market

Company’s pembrolizumab-based immune checkpoint inhibitor exhibited success  against solid tumors in IND-enabling studies by simultaneously activating immune cells and promoting their infiltration into solid tumors Presentation at Nova Southeastern …

Shenandoah Telecommunications Appoints Angela M. Olsen as General Counsel

Shenandoah Telecommunications Appoints Angela M. Olsen as General Counsel

EDINBURG, Va., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announces that Angela M. Olsen has joined the Company as Vice President-Legal and General Counsel. Ms. Olsen will be a member …

New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025

New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025

DUBLIN and BRIDGEWATER, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced upcoming presentations at the European Society of Cardiology (ESC) Congress 2025, August 29th-September 1st, in Madrid, Spain, where new …

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from August 18, 2025 to August 22, 2025 AMSTERDAM – August 25, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), …

Arnatar Therapeutics Emerges from Stealth and Announces Receipt of FDA Orphan Drug and Rare Pediatric Disease Designations for ART4

Arnatar Therapeutics Emerges from Stealth and Announces Receipt of FDA Orphan Drug and Rare Pediatric Disease Designations for ART4

SAN DIEGO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Arnatar Therapeutics, a biotechnology company pioneering RNA-based therapies for severe and underserved diseases, emerges from stealth today and announces that the U.S. Food and Drug Administration (FDA) has …

M&M Food Market Lowers Prices on Over 150 Items to Help Canadians Weather the Cost-of-Living Crisis

M&M Food Market Lowers Prices on Over 150 Items to Help Canadians Weather the Cost-of-Living Crisis

Toronto, Aug. 25, 2025 (GLOBE NEWSWIRE) -- As the cost of living continues to strain household budgets, with 75% of Canadians citing food affordability[1]as a top concern, M…

Drone Warfare Market on Track for $30.5 Billion by 2028: Growth Opportunity & Future of Defense

Drone Warfare Market on Track for $30.5 Billion by 2028: Growth Opportunity & Future of Defense

Delray Beach, FL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The report "Drone Warfare Market Size, Share …

Smarter, Faster, and More Human: Cerence AI and Volkswagen Advance Partnership to Deliver Next-Gen In-Car Conversations

Smarter, Faster, and More Human: Cerence AI and Volkswagen Advance Partnership to Deliver Next-Gen In-Car Conversations

BURLINGTON, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced the next evolution of its successful collaboration with the Volkswagen …

SCYNEXIS to Participate in the H.C. Wainwright 27th Annual Global Conference September 8 – 10, 2025

SCYNEXIS to Participate in the H.C. Wainwright 27th Annual Global Conference September 8 – 10, 2025

JERSEY CITY, N.J., Aug. 25, 2025 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced that the Scynexis senior …

Cassava Sciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Cassava Sciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

AUSTIN, Texas, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders, such as Tuberous …

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

STOUGHTON, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will present nine posters showcasing real-world data from its differentiated pain portfolio at PAINWeek 2025, taking place in Las Vegas, NV …

Avalyn to Participate in Multiple Upcoming Investor Conferences in September

Avalyn to Participate in Multiple Upcoming Investor Conferences in September

CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on the development of inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced that management …

Locafy to Present at the 2025 Gateway Conference on September 3rd

Locafy to Present at the 2025 Gateway Conference on September 3rd

PERTH, Australia, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Locafy Limited (Nasdaq: LCFY, LCFYW) (“Locafy” or the “Company”), a globally recognized software-as-a-service technology company specializing in ”entity-based” search engine optimization (SEO), will …

NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in September

NewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in September

NAARDEN, The Netherlands and MIAMI, Aug. 25, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …

Human resources: Build employer brand and attract top talent with new marketing program from CPHRNS and Anamorphiq

Human resources: Build employer brand and attract top talent with new marketing program from CPHRNS and Anamorphiq

Halifax, N.S., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Chartered Professionals in Human Resources Nova Scotia (CPHRNS), in partnership with digital-first PR agency Anamorphiq, today introduced the CPHRNS Workforce Communications Program. This exclusive new …

Ardelyx to Participate in Upcoming Investor Conferences

Ardelyx to Participate in Upcoming Investor Conferences

WALTHAM, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …

Ascentage Pharma to Participate in Three Upcoming Investor Conferences in September 2025

Ascentage Pharma to Participate in Three Upcoming Investor Conferences in September 2025

ROCKVILLE, Md. and SUZHOU, China, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial stage, integrated biopharmaceutical company engaged in the …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions